Cost-effectiveness of first-line treatments in metastatic renal cell carcinoma.

Cost-effectiveness of first-line treatments in metastatic renal cell carcinoma. Curr Med Res Opin. 2020 Dec 07;:1 Authors: Benton JZ, Klaassen Z, Wallis CJD PMID: 33287576 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research